ɬÀï·¬

Journal News

The metabolic trigger that activates sperm

John Arnst
Nov. 13, 2020

When viewed under a microscope, sperm cells typically look like eager swimmers with a singular purpose. But despite the haste that their flagella and behavior imply, sperm are hardly ready to go at a moment’s notice.

Leeuwenhoek-art-445x963.jpg
WELLCOME TRUST COLLECTION
Antoni Van Leeuwenhoek first observed the structure of sperm in 1677, which
he detailed here in his 1719 book "Opera omnia."

After ejaculation, they need up to an hour to undergo a process of posttranslational modifications called capacitation, which alters their heads so they can merge with an egg and changes the movement patterns of their tails to a frenzied state of hyperactivity before they are able to fertilize that egg. While in this state, sperm shut off their typical metabolic pathway, oxidative phosphorylation, and instead begin to rely on glycolysis for their final push. One of the biochemical changes that makes capacitation possible is the covalent addition of sialic acid to the terminal end of glycoproteins, or sialyation, a process that only affects a handful of proteins on sperm but is essential to fertilization.

To better understand the role that sialyation plays in fertilization, researchers at the University of Newcastle used a tandem mass spectrometry and liquid chromatograph approach to examine the glycoproteomic changes in sperm cells that had been made to undergo capacitation through incubation for 90 minutes. They detailed in the journal Molecular & Cellular Proteomics.

“We wanted to know, if we take sperm before and after capacitation, what would change in terms of the sialic acid proteins,” said , a Newcastle scientist who researches the proteomics of sperm and male fertility. “And the answer was extremely little, which was quite surprising. Very, very, very few proteins, 0.4% or something stupidly small.”

But the paltry six proteins that Baker and his colleagues found had decreased sialic acid content, which he attributed to either shedding or the activity of a glycosidase, turned out to be glycolic red herrings after they noted a lone protein that had increased sialyation.

That protein’s name? Aconitase, or ACO2, an enzyme in the citric acid cycle that catalyzes the isomerization of citrate to isocitrate. Thanks to a computer model built by Vincenzo Carbone, a co-author at the Grasslands Research Centre, the researchers then found that sialyation causes a conformational change in aconitase’s alpha helix that distorts its active site and completely shuts it down, along with oxidative phosphorylation as a whole.

“We think that would suggest that when you stop oxidative phosphorylation and shuttle the metabolic pathway through to glycolysis, that’s probably a trigger for the hyperactivation, or probably helps it in some way, but we don’t know,” Baker said.

However, hyperactivity itself is not well understood. According to Baker, researchers currently have multiple competing theories about its role and purpose in fertilization.

“The only thing that we know for sure is that without hyperactivation, you just don’t get fertility.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
John Arnst

John Arnst was a science writer for ASBMB Today.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

What’s in a diagnosis?
Essay

What’s in a diagnosis?

Sept. 4, 2025

When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.

Peer through a window to the future of science
Annual Meeting

Peer through a window to the future of science

Sept. 3, 2025

Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.

Glow-based assay sheds light on disease-causing mutations
Journal News

Glow-based assay sheds light on disease-causing mutations

Sept. 2, 2025

University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent ɬÀï·¬ paper.

A game changer in cancer kinase target profiling
Journal News

A game changer in cancer kinase target profiling

Aug. 19, 2025

A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent ɬÀï·¬ paper.

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.